|
|
|
Volumn 37, Issue 1, 2010, Pages
|
|
The dual vitamin D pathways: considerations for adequate supplementation.
a
a
Cytochroma Inc
(Canada)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COLECALCIFEROL;
ERGOCALCIFEROL;
VITAMIN;
VITAMIN D;
ARTICLE;
AUTOCRINE EFFECT;
CHRONIC KIDNEY FAILURE;
COMORBIDITY;
DIET SUPPLEMENTATION;
DRUG EFFECT;
ENDOCRINE SYSTEM;
HEALTH CARE POLICY;
HOSPITALIZATION;
HUMAN;
METABOLISM;
NUTRITIONAL STATUS;
PATIENT SELECTION;
PHYSIOLOGY;
SECONDARY HYPERPARATHYROIDISM;
VITAMIN D DEFICIENCY;
AUTOCRINE COMMUNICATION;
CHOLECALCIFEROL;
COMORBIDITY;
DIETARY SUPPLEMENTS;
ENDOCRINE SYSTEM;
ERGOCALCIFEROLS;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
KIDNEY FAILURE, CHRONIC;
NUTRITION POLICY;
NUTRITIONAL STATUS;
PATIENT SELECTION;
SEVERITY OF ILLNESS INDEX;
VITAMIN D;
VITAMIN D DEFICIENCY;
VITAMINS;
|
|
EID: 77950895492
PISSN: 1526744X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
